Abstract
At the present time, clinicians managing patients with metastatic breast cancer face a challenging problem. Therapeutic strategies that include chemotherapy, hormonal therapy, and combination approaches have been based almost exclusively on published experience from clinical trials that antedate common adjuvant systemic therapy use. In fact, most studies in advanced breast cancer excluded patients with any prior hormonal or chemotherapy use as part of the study design. Thus, although the majority of breast cancer patients who develop metastatic disease may have received prior adjuvant chemotherapy and/or hormonal therapy, few prospective trials have evaluated therapeutic approaches for this population.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ahmann FR, Jones SE, and Moon TE. The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer. J Surg Oncol 37:116–122, 1988.
2. Australian and New Zealand Breast Cancer Trials Group. A randomized trial in postmenopausal patients with advanced breast cancer comparing endocrine and cytotoxic therapy given sequentially or in combination. J Clin Oncol 4:186–193, 1986.
Bitran JD, Desser RK, Shapiro CM, et al. Response to secondary therapy in patients with adenocarcinoma of the breast previously treated with adjuvant chemotherapy. Cancer 51:381–384, 1983.
Bonadonna G. Conceptual and practical advances in the management of breast cancer. J Clin Oncol 7:1380–1397, 1989.
Buchner JC, Ingle JN, and Everson LK. Results of salvage hormonal therapy and salvage chemotherapy in women failing adjuvant chemotherapy after mastectomy for breast cancer. Breast Cancer Res Treat 13:135–142, 1989.
Buzdar AU, Legha AA, Hortobagyi GN, et al. Management of the breast cancer patient failing adjuvant chemotherapy with Adriamycin-containing regimens. Cancer 47:2798–2806, 1981.
Castiglione M, Hacking A, Tattersall MN, et al. Systemic treatment for the first relapse of breast cancer after adjuvant therapy using the same treatment again. Proc Am Soc Clin Oncol 8:156, 1989.
Cavilli F, Beer M, Martz, et al. Concurrent or sequential use of cytotoxic chemotherapy and hormone treatment in advanced breast cancer: Report on the Swiss Group for Clinical Cancer Research. Br Med J 286:5–8, 1983.
Chism SE, Brown BS, and Hoyle BA. Breast cancer treatment: Evolving approaches but stable results. Int J Radiat Oncol, Biol Phys 12:2073–2078, 1986.
Chlebowski RT, Weiner JM, Reynolds R, et al. Long-term survival following relapse after 5-FU but not CMF adjuvant breast cancer therapy. Breast Cancer Res Treat 7:23–29, 1986.
Chlebowski RT, Weiner JM, Reynolds R, Luce J, Bulcavage L, and Bateman JR. Western Cancer Study Group trial of CMF vs. 5-FU as adjuvant breast cancer therapy. Treatment of Early Breast Cancer, EBCTCG, Oxford Press, Oxford, p. 129, 1990.
Colozza M, Tonato M, Grignani F, et al. Low-dose mitomycin and weekly low-dose doxorubicin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, and 5-fluorouracil. Cancer 62: 262–265, 1988.
Colozza M, Gori S, Mosconi AM, et al. Chemotherapy with cisplatin, doxorubicin, and cyclophosphamide (CAP) in patients with metastatic breast cancer. Am J Clin Oncol 12:481–485, 1989.
Davidson NE and Lippman ME. Treatment of metastatic breast cancer. In: Diagnosis and Management of Breast Cancer, ME Lippman, AS Lichter, and DN Danforth Jr (eds). W.B. Saunders, Philadelphia, 1988, pp. 375–406.
Dittrich C, Jakesz R, Pirich K, et al. Possible adverse effect of failed adjuvant chemotherapy for recurrent breast cancer. J Cancer Res Clin Oncol 113:488–494, 1987.
Early Breast Cancer Trialists Collaborative Group. The effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. N Engl J Med 319:1681–1692, 1989.
Forander T, Rutqvist LE, and Glas U. Response to tamoxifen and fluoxymesterone in a group of breast cancer patients with disease recurrence after cessation of adjuvant tamoxifen. Cancer Treat Rep 71:685–688, 1987.
Goldhirsch A, Gelber RD, and Castiglione M. Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: Patterns and prognoses. J Clin Oncol 6:89–97, 1988.
Henderson IC. Chemotherapy for metastatic disease. In: Breast Diseases, JR Harris, S Hellman, IC Henderson, and DW Kinne (eds). J.B. Lippincott, Philadelphia, 1987, pp. 428–479.
Henderson IC. Adjuvant systemic therapy: State of the art. Breast Cancer Res Treat 14:3–22, 1989.
Henderson IC, Allegra JC, Woodcock T, et al. Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer. J Clin Oncol 7:560–571, 1989.
Henderson IC, Harris JR, Kinne DW, and Hellman S. Cancer of the Breast. In: Cancer: Principles and Practice of Oncology, VT DeVita, S Hellman, and SA Rosenberg (eds). J.B. Lippincott, Philadelphia, 1989, pp. 1197–1268.
Kau S, Buzdar A, Frye D, et al. Survival experience of patients (pts) failing adjuvant therapy in comparison to pts with metastatic breast cancer. Proc Am Soc Clin Oncol 7:32, 1988.
Kosmidis PA, Kondyls D, and Lissaios B. Salvage chemotherapy for breast cancer patients treated with adjuvant adriamycin-containing regimen. Oncology 47:1–3, 1990.
Morris DM, Elias EG, Didolkar MS, et al. The response to further chemotherapy in patients with carcinoma of the breast who progressed while receiving adjuvant therapy. J Surg Oncol 29:154–157, 1985.
Morrison JM, Howell A, Kelly KA, et al. West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: Results after a median follow-up of 7 years. I. Patients without involved axillary nodes. Br J Cancer 60:911–918, 1989.
Muss HB, Smith LR, and Cooper MR. Tamoxifen rechallenge: Response to tamoxifen following relapse after adjuvant chemohormonal therapy for breast cancer. J Clin Oncol 5:1556–1558, 1987.
Noguchi S, Miyauchi K, Nishizawa Y, et al. Influence of adjuvant chemotherapy for operable breast cancer on results of treatment at relapse. Oncology 46:69–73, 1989.
Pronzato P, Amoroso D, Ardizzoni A, et al. Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancer. Am J Clin Oncol 10:404–406, 1987.
Ribeiro G and Swindells R. The Christie Hospital tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma — 7 year results. Eur J Cancer Clin Oncol 22:897–900, 1985.
Taylor SG, Gelman RS, Falkson G, et al. Combination chemotherapy compared to tamoxifen as initial therapy for stage IV breast cancer in elderly women. Ann Intern Med 104:455, 1986.
Valagussa P, Brambilla C, Zambetti M, and Bonadonna G. Salvage treatments in relapsing resectable breast cancer. Rec Results Cancer Res 115:69–76, 1989.
Valagussa P, Tancini G, and Bonadonna G. Salvage treatment of patients suffering relapse after adjuvant CMF chemotherapy. Cancer 58:1411–1417, 1986.
Wendt AG, Jones SE, and Salmon SE. Salvage treatment of patients relapsing after breast cancer adjuvant chemotherapy. Cancer Treat Rep 64:269–273, 1980.
Wilson KS and Paterson AH. First-line mitoxantrone chemotherapy for advanced breast cancer. Cancer Treat Rep 70:1021–1022, 1986.
Zaniboni A, Marpicati P, Simoncini E, et al. Cyclophosphamide, epirubicin and cisplatin (CEP) in advanced breast cancer: Preliminary results. Anticancer Res 7:813–816, 1987.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Chlebowski, R.T. (1992). Treating the relapsed patient. In: Henderson, I.C. (eds) Adjuvant Therapy of Breast Cancer. Cancer Treatment and Research, vol 60. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3496-9_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3496-9_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6550-1
Online ISBN: 978-1-4615-3496-9
eBook Packages: Springer Book Archive